Sodium Acetate Injection, Solution, Concentrate
Product Images NDC 71357-009

This is a description of Sodium Acetate injection, USP. It contains 164 mg of sodium acetate per mL and may also include acetic acid for pH adjustment. The solution has an osmolality of 4 mOsmol/mL and a pH range of 6.0 to 7.0. It is sterile, nonpyrogenic, and intended for preparing admixtures. The product is to be used under a laminar flow hood with aseptic technique. Each vial should be discarded within 4 hours after entry. It is advised to dilute the solution and store it between 20°C to 25°C. The Sodium Acetate injection is not for direct infusion and contains no more than 200 mcg/L of aluminum. Additionally, it is a Pharmacy Bulk Package and should only be used for intravenous purposes. The product is distributed by Milla Pharmaceuticals Inc. and is made in Italy.*

This text provides details about an injectable solution containing sodium acetate anhydrous and other components for intravenous use. The solution is sterile, nonpyrogenic, and must be prepared for admixtures only using proper techniques and equipment. It includes information about dosage, storage conditions, pH level, and cautions for use. Additionally, the text mentions the manufacturer and location details.*

This information is a label from a pharmaceutical product containing sodium acetate in sterile, nonpyrogenic form for intravenous use. It should be used for preparing admixtures only, and doses should be transferred to appropriate intravenous infusion solutions using a sterile dispensing set or transfer device. The product should be discarded 4 hours after initial entry, and caution must be taken with dilution. Storage instructions include keeping it at 20°C to 25°C. The product is manufactured by Milla Pharmaceuticals Inc. in Italy and must be used under a laminar flow hood with aseptic technique.*

This is a product label for Sodium Acetate Injection, USP. It contains essential information such as dosage, composition (each mL contains sodium acetate, anhydrous 164 mg), pH adjustment, and storage instructions. The label also includes important warnings and precautions for proper use, emphasizing that it should be diluted before administration. The product is for intravenous use only and should be prepared using sterile techniques. It is advised to discard the vial after 4 hours of initial entry. Additionally, the label specifies that the product is sterile and nonpyrogenic.*

This text appears to be a description of a pharmaceutical product - Sodium Acetate injection, USP. It contains 400 mEq/100 mL of sodium acetate anhydrous and may also contain acetic acid for pH adjustment. The product is sterile, nonpyrogenic and is used for preparing admixtures. The container should be discarded 4 hours after initial entry and should be used with proper aseptic techniques. It is a Pharmacy Bulk Package and not for direct infusion, with caution that it must be diluted before use. The product is distributed by Milla Pharmaceuticals Inc, and is made in Italy. It is for intravenous use only and should be stored at 20°C to 25°C.*

This text contains important information about a Pharmacy Bulk Package of Sodium Acetate Injection, USP. It includes details such as dosage, administration instructions, storage conditions, caution for dilution, and the manufacturer's information. It specifies that it is sterile, non-pyrogenic, and intended for intravenous use only. The text emphasizes the need for dilution before use and provides detailed guidance on the proper handling of the product, advising against the use of a syringe with a needle. Additionally, it highlights the importance of discarding the vial within 4 hours after initial entry and mentions the storage temperature range. The product contains no more than 400 mcg/L of aluminum and is distributed by Milla Pharmaceuticals Inc.*